Gastrointestinal bleeding in heart disease patients on blood thinners
Part of Digestive system, Heart & circulation clinical trials.
This trial is looking at patients with ischemic heart disease who are taking one or two antiplatelet drugs (like aspirin or clopidogrel) and have had gastrointestinal bleeding. The goal is to study this problem and find better ways to manage it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with ischemic heart disease (blocked heart arteries).
- You are taking one or two antiplatelet medications (like aspirin or clopidogrel).
- You have had a gastrointestinal bleed (vomiting blood, black/tarry stools, or blood in stool).
- You are not taking blood thinners like warfarin or rivaroxaban.
- You do not have a bleeding disorder or other serious health condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from patients who come to the emergency room with gastrointestinal bleeding while taking certain newer blood thinners. It aims to better understand and manage this type of bleeding.
This trial looks at blood changes in people who have been diagnosed with angiodysplasia (abnormal blood vessels in the gut) that caused bleeding. By studying these patients, researchers hope to better understand the link between angiodyplasia and blood disorders.
This trial compares a potassium-competitive acid blocker to a proton pump inhibitor to help prevent stomach or intestinal bleeding in people at high risk who take blood-thinning medicines. It may help reduce dangerous GI bleeding while you stay on heart/stroke medicines.
This trial studies which blood-thinner (antiplatelet) strategy is safest and most effective for people at high risk of bleeding after a procedure called PCI. It also looks at longer-term outcomes and whether adjusting treatment can improve safety without losing heart protection.
This trial looks at whether a “drug-coated balloon” used during a heart procedure (PCI) is safer or better for people who are at higher risk of bleeding while on blood thinners. It may help reduce complications around the time of the procedure in people like you.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
Hear when a new Antiplatelet Drugs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.